A chiral pool protocol toward the synthesis of the smenamide family of natural products is described. Two stereoisomers of smenamide A, namely, ent-smenamide A and 16-epi-smenamide A were synthesized with a 2.6 and 2.5% overall yield, respectively. Their carboxylic acid moieties were assembled starting from S-citronellene via two Wittig reactions and a Grignard process. Its coupling with either (S)-or (R)dolapyrrolidinone, synthesized from Boc-L-Phe and Boc-D-Phe, respectively, was accomplished by using the Andrus protocol. This work also established the previously unknown relative and absolute configurations of smenamide A. Figure 1. Structures of smenamide A (1) and B (2) as determined in a previous study. 5 Article
■ INTRODUCTION
Marine sponges are considered to be one of the most productive sources 1 of novel scaffolds for use as leads in antiinflammatory, immunomodulating, and anticancer drug research. 2−4 Smenamides A (1) and B (2) ( Figure 1 ) are chlorinated hybrid peptide/polyketide metabolites isolated in microgram amounts from the Caribbean sponges Smenospongia aurea 5 and Smenospongia conulosa. 6 The two smenamides differ only in the configuration of the C-13 double bond, which is E in smenamide A. Many of the structural motifs in smenamides are usually found in cyanobacterial metabolites, and it is likely that smenamides themselves are produced by a cyanobacterial symbiont in the sponge. In particular, the vinyl chloride function is shared with compounds such as jamaicamides 7 and malingamides 8 and the recently isolated smenothiazoles 9 and conulothiazoles. 6 The dolapyrrolidinone terminus is a structural feature found, among others, in dolastatin-15, 10 mycapolyols A−F, 11 and belamide A. 12 Smenamides are bioactive substances and promising anticancer lead compounds. In particular, smenamide A is strongly cytotoxic on lung cancer Calu-1 cells at nanomolar concentrations 5 through a clear proapoptotic mechanism. Further pharmacological studies of smenamides were hampered by the very limited amounts available, and total synthesis is a way to overcome this problem. Here, we report an efficient chiral pool convergent approach for the total synthesis of smenamides and its analogues, which resulted in the synthesis of ent-smenamide A and 16-epi-smenamide A.
■ RESULTS AND DISCUSSION Smenamide A (1) contains two stereogenic centers, C-8 and C-16, whose configurations could not be assigned in the original study. 5 Therefore, before designing the synthetic plan, the configuration at C-8 was determined using an improved Marfey's method. 6, 13 In particular, the phenylalanine residue obtained from the degradation of smenamide A was found to have the L configuration based on the liquid chromatography mass spectrometry (LC−MS) retention time of its 1-fluoro-2,4dinitrophenyl-5-L-alaninamide (L-FDDA) derivative (see Figures S1 and S2) . Determination of the configuration at C-16 is not trivial, and indeed, this was one of the objectives of the present synthesis work. Smenamide A is a small but densely functionalized molecule comprising an N-methylacetamide, a chlorovinyl, and a tetramic acid unit in its enol ether form engaged into a mixed imide bond with an α,β-unsaturated carboxylic acid unit. A central point in a synthetic plan toward smenamide A is the construction of the Z-chlorovinyl function. Various approaches have been used to build this function in related substances, 14 but relatively a few methods have been reported for the stereoselective preparation of chloroolefins. Paige et al. 15 used the palladium-mediated regio-and stereospecific silylstannylation of a terminal alkyne 16 to set the basis for the stereoselectivity. However, the chlorodesilylation required to generate the chlorovinyl moiety from the intermediate alkenylsilane resulted in a moderate yield (42%), and similar results were obtained by others, 17a,b with yields in the range 45−51%. We envisioned that this approach, although elegantly conducted to the required function in a stereoselective manner, would neither provide any advantage in terms of the overall efficiency of the synthesis nor decrease the need for chromatographic separations. The Wittig olefination, on the other hand, has been reported to be an easy, efficient, and direct process to build the chloroolefin function. 14a−d,f Although this approach suffers from the lack of stereoselectivity, sound precedents exist for the photochemical isomerization of strictly related chloroolefins, 14d opening the way to recycling the unwanted stereoisomer. Therefore, we decided to include this latter reaction in our plan.
Our retrosynthetic analysis is depicted in Scheme 1. Disconnection of smenamide A at the mixed imide function gave carboxylic acid 3 (C12−C27 fragment) and pyrrolinone 4 (C1−C11 fragment). Further simplification of fragment 3 could be achieved by the cleavage of the two carbon−carbon double bonds and the C24−N bond. This led to the fully protected C15−C24 triol 5 as a versatile intermediate, where each alcohol function could be transformed into one of the functional groups belonging to fragment 3. The protecting groups in triol 5 were chosen in such a way that the tertbutyldimethylsilyl (TBS), Bn, and tert-butyldiphenylsilyl (TBDPS) groups could be selectively removed according to the order of installation of the three functionalities, namely, first the N-methylacetamide, then the chlorovinyl function, and finally the α,β-unsaturated acid unit. The presence of a methyl group at C-16 in 5 suggested a further C20−C22 disconnection, revealing the C15−C20 fragment 6 that was in turn traced back to citronellene. The protected bromoalcohol 7 was recognized as the functionalized form of the remaining C22−C24 structural fragment. All this implied that in the synthetic direction, two Wittig reactions, one of them Eselective (generating the E C13−C15 bond), and a Grignard reaction (generating the C20−C21 bond), could be used to build the whole carbon skeleton of the acid moiety, starting from a suitably functionalized C15−C20 fragment. It is important to say that the C-8 stereogenic center in the dolapyrrolidinone moiety of smenamide A is prone to racemization. 18 Therefore, a racemization-free synthetic route has been used 18, 19 to obtain fragment 4 starting from Meldrum's acid and Boc-protected L-phenylalanine (Scheme 1).
As the configuration at C-16 in smenamide A is unknown, the citronellene enantiomer used as the starting material was arbitrarily chosen. Thus, starting from the cheaper, commercially available S-citronellene, the C15−C20 fragment 6 was synthesized as shown in Scheme 2. In particular, the chemoselective epoxidation of the trisubstituted double bond, followed by acid-catalyzed epoxide opening and benzoylation of the secondary alcohol function gave benzoate 8, as a 1:1 mixture of two diastereomers, in an 82% yield (over three steps). The terminal olefin was dihydroxylated under Sharpless conditions with OsO 4 (catalyst)/N-methylmorpholine N-oxide (NMO), and the obtained diol was cleaved with sodium periodate to afford the C-15 aldehyde. Reduction of the latter with sodium borohydride and protection of the primary alcohol with the TBDPS group gave compound 9 in a 50% yield (over four steps). Finally, the reductive removal of the benzoate with lithium aluminum hydride and the cleavage of the resultant diol afforded aldehyde 10, which was used in the next Grignard reaction without further purification. Reaction of aldehyde 10 with the Grignard reagent 11, prepared from the commercially available TBS-protected 3-bromo-propan-1-ol 7, afforded alcohol 12 as a 1:1 mixture of two diastereomers in a 72% yield (over three steps). Transformation of alcohol 11 into the corresponding benzyl ether under usual conditions [NaH, BnBr, and tetrabutylammonium iodide (TBAI) (catalytic amount), 91% yield] completed the preparation of the fully protected triol 5. Then, installation of the N-methylacetamide function was accomplished in three steps (Scheme 3). Removal of the TBS group with AcOH/tetrahydrofuran(THF)/H 2 O (3:1:1) followed by tosylation and treatment of tosylate with excess NH 2 CH 3 (40% soln in water) 20 afforded the secondary amine 13. Acetylation of the latter with AcCl/triethylamine (TEA) gave the desired N-methylacetamide 14 in a 65% overall yield (over four steps), as an approximately 1:1 mixture of rotamers.
Ketone 15 (Scheme 3) required for the Wittig olefination was obtained through the hydrogenolysis of the benzyl ether function of 14, followed by oxidation of the delivered alcohol with the catalytic system tetrapropylammonium perruthenate (TPAP) (5 mol %)/NMO, under Ley's conditions 21 (79% over two steps).
Initially, the Wittig process was tested using the model compound 16 (Scheme 4) obtained from alcohol 12 through TPAP/NMO catalytic oxidation (90%). 21 The required phosphonium salt, (chloromethyl)triphenylphosphonium iodide 17 (Scheme 4), was prepared by the reaction of iodochloromethane with triphenylphosphine. 14a According to the literature, the Wittig reaction was conducted in the presence of nBuLi in THF at −78°C. 14c,d However, although the mass recovery was satisfying, these conditions led to a large amount of the methylenation product 19 besides the expected chlorovinyl compound 18 (1:1 mixture of geometric isomers; 18/19 1:1, Scheme 4). A similar result was obtained when using the synthetic intermediate 15. Pleasingly, the use of potassium tert-butoxide 14a as the base smoothly led to the desired product both with the model ketone 16 (18, 76%) and with compound 15. In the latter case, a 3:2 mixture of the two diastereomers 20 and 21, in favor of the desired Z isomer, was obtained with an 83% yield (Scheme 4). The two isomers could be easily separated using column chromatography, and Rotating-frame Overhauser Effect Spectroscopy (ROESY) data allowed us to assign the double bond configuration in each isomer.
As planned, to increase the yield of the synthetically useful isomer 20, photochemical isomerization of the E isomer 21 was addressed. According to the literature, 14d irradiation of 21 with λ > 300 nm light (Scheme 4), in the presence of a catalytic amount of benzophenone, induced its conversion to the Z isomer 20 in a 20% yield. Although low-yielding, this process (unoptimized) was very clean, leading to only isomer 20 and unreacted 21, thus allowing recycling of this late synthetic material. Finally, the installation of the α,β-unsaturated acid moiety was addressed (Scheme 5). Removal of the TBDPS group in 20 with tetrabutylammonium fluoride (TBAF)/THF followed by oxidation of the alcohol 22 with the TPAP (5 mol %)/NMO system gave aldehyde 23, which was subjected to the subsequent E-selective Wittig olefination without further purification. Thus, the reaction of 23 with Ph 3 PCH(Me)-CO 2 Et afforded α,β-unsaturated ester 24, which was hydrolyzed to acid 3 on treatment with lithium hydroxide hydrate. Overall, compound 3 was obtained with a 53% yield over four steps.
Pyrrolinone moiety 4 was synthesized in a 57% overall yield according to the previously developed racemization-free route shown in Scheme 6. 19 Briefly, the reaction of (S)-Bocphenylalanine with Meldrum's acid, followed by the reflux of the crude in AcOEt for 30 min gave the Boc-protected tetramic acid 25. Methylation of the latter under Mitsunobu conditions and the removal of the Boc protecting group gave the desired compound 4. The optical rotation measured for this material well matched the reported value ([α] D = −62.3; lit. −63), 22 indicating its high enantiopurity.
Finally, the two building blocks 3 and 4 were coupled by using the Andrus protocol 23 (Scheme 7). Thus, the acid moiety 3 was activated as the pentafluorophenyl ester 26 by reaction with C 6 F 5 OH/N, N′-dicyclohexylcarbodiimide (DCC) (82%). Coupling of 26 with an excess of lithium imidate derived from pyrrolinone 4 proceeded smoothly, giving the coupling product 27 in a 91% yield. Overall, compound 27 was obtained in a 2.5% yield with a longest linear sequence (LLS) of 23 steps.
Unfortunately, the proton spectrum of the synthetic smenamide A did not match that of the natural smenamide A (see Supporting Information). In particular, inter alia, the H-15 signals (for the two rotamers) adjacent to the C-16 stereogenic center had noticeably different shapes (see Supporting Information). This implied that compound 27 was 16-epismenamide A and, consequently, that the natural smenamide A possessed the R configuration at C16. At this point, to confirm the structure of smenamide A, the synthesis of ent-smenamide A was carried out by coupling (R)-pyrrolinone 28 24 with pentafluorophenyl ester 26 (Scheme 8). Starting from (R)-Bocphenylalanine, compound 28 was obtained in a straightforward manner in a 47% overall yield. Finally, the coupling of compounds 26 and 28 using the Andrus method proceeded smoothly in this case too to give ent-smenamide A 29 in an 88% yield. The proton spectrum of this material perfectly matched that of natural smenamide A, confirming that the configuration at C-16 in smenamide A was indeed R. In addition, as expected, natural smenamide A and ent-smenamide A had mirror-image CD spectra. Compound 29 was obtained in a 2.6% overall yield (LLS = 23 steps).
■ CONCLUSIONS
In conclusion, the syntheses of ent-smenamide A and 16-epismenamide A have been accomplished with a 2.6 and 2.5% overall yield, respectively, in 23 steps. The synthesis of natural smenamide A and its analogues, according to the developed synthetic protocol, and the evaluation of the antitumor activity of the synthesized substances are currently under way.
■ EXPERIMENTAL SECTION
General Experimental Methods. All reagents and anhydrous solvents were purchased (Aldrich and Fluka) at the highest commercial quality and used without further purification. β-citronellene was purchased from Sigma Aldrich (ee ≥ 98.5%). Where necessary, flame-dried and argon-charged glassware was used. The reactions were monitored using thinlayer chromatography (TLC) carried out on precoated silica gel plates (Merck 60, F254, 0.25 mm thick). Merck silica gel (Kieselgel 40, particle size 0.063−0.200 mm) was used for the column chromatography. MgSO 4 was used as a drying agent for aqueous workup. Nuclear magnetic resonance (NMR) experiments were performed using Varian Unity Inova spectrometers at 400, 500, and 700 MHz in CDCl 3 . Proton chemical shifts were referenced to the residual CHCl 3 signal (7.26 ppm). 13 C NMR chemical shifts were referenced to the solvent (77.0 ppm). Abbreviations for signal coupling are as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, and b = broad. Infrared spectra were recorded under neat conditions on a PerkinElmer spectrum 100R spectrophotometer and are reported in cm −1 . Optical rotations were measured using a JASCO P-2000 polarimeter at the sodium D line. ECD spectra were recorded using a JASCO J-710 spectropolarimeter. HRMS spectra were recorded by infusion on a Thermo LTQ Orbitrap XL mass spectrometer equipped with an electrospray source in the positive mode using MeOH as the solvent.
Benzoate 8.
According to a literature procedure, 25 β-citronellene (10 mL, 7.6 g, 54.9 mmol) was converted into the corresponding 6,7epoxide (8.44 g, 100%), a smelling colorless oil. To a stirred solution of diol 30 (7.34 g, 42.6 mmol) in pyridine (20 mL), benzoyl chloride (0.052, 6 mL) was added. After 2.5 h, water (8 mL) was added, and the mixture was stirred for 15 min in a water bath and then dried. The residue was taken up in CHCl 3 (50 mL) and washed with a saturated aqueous NaHCO 3 solution and water. The organic phase was dried, filtered, and evaporated in vacuo. Purification over silica gel (hexane/EtOAc, 9:1) gave benzoate 8 (11.0 g, 94%), as a colorless oil, a mixture of two diastereomers. IR (neat) To a stirred solution of benzoate 8 (7.93 g, 28.7 mmol) in acetone/water (120 mL, 5:1), OsO 4 (369 mg, 14.5 mmol, 5 mol %) was added. After 2 h, the reaction was quenched by the addition of solid Na 2 S 2 O 5 (720 mg, 2.9 mmol), and the reaction mixture was stirred for further 30 min. Acetone was evaporated under reduced pressure, and the resultant aqueous suspension was extracted using EtOAc (3 × 50 mL). The organic phase was dried and evaporated in vacuo to give diol 31 (8.71 g) as a colorless oil. An analytically pure sample of this compound was obtained using chromatography over silica gel (CHCl 3 /CH 3 To a stirred solution of diol 31 (8.69 g, 29.0 mmol) in acetone/water (180 mL, 5:1) at 0°C, sodium periodate (12.35 g, 58.0 mmol) was added. After a few minutes, a large amount of a white solid was precipitated. After 4 h, the reaction mixture was filtered under vacuum, and the precipitate was carefully washed with acetone. The solvent was evaporated in vacuo, and the aqueous suspension was extracted using EtOAc (3 × 30 mL). The organic layer was dried and concentrated in vacuo to give aldehyde 32 as a colorless oil (5.54 g), which was applied to the next step without further purification.
To a stirred solution of aldehyde 32 (5.52 g, 20.0 mmol) in methanol (70 mL) at 0°C, NaBH 4 (376 mg, 9.9 mmol) was added in portions. After 1 h, the reaction was quenched by dropwise addition of CH 3 COOH (3.5 mL). Then, the reaction mixture was concentrated in vacuo, treated with a saturated aqueous solution of NaHCO 3 (30 mL), and extracted using EtOAc (3 × 30 mL). The organic phase was dried and evaporated under reduced pressure to give crude 33 (5.29 g). An analytically pure sample of this compound was obtained using chromatography over silica gel (CHCl 3 /CH 3 OH, 9:1) for characterization. Mixture of two diastereomers, IR (neat) To a stirred solution of alcohol 33 (5.29 g, 19.0 mmol) in dimethlformamide (DMF, 19 mL), imidazole (1.56 g, 23 mmol) and tert-butyldiphenylsilyl chloride (6.32 g, 5.88 mL, 23 mmol) were sequentially added at room temperature (RT). After 40 min, DMF was evaporated in vacuo, and the residue was taken up in CHCl 3 and washed with brine. The organic phase was dried, concentrated in vacuo, and purified using To a stirred solution of diol 34 (4.83 g, 11.6 mmol) in acetone/water 5:1 (57 mL) at 0°C, sodium periodate (4.98 g, 23.2 mmol) was added. After a few minutes, a large amount of white solid precipitated. After 4 h, the reaction mixture was filtered under vacuum, and the precipitate was carefully washed with acetone. The solvent was evaporated in vacuo, and the aqueous suspension was extracted using EtOAc (3 × 30 mL). The organic layer was dried and concentrated in vacuo to give aldehyde 10 as a colorless oil (4.34 g), which was applied to the next step without further purification. 1 Alcohol 12.
ACS Omega
To a suspension of magnesium turnings (583 mg, 24.0 mmol) in anhydrous THF (30 mL), a catalytic amount of iodine was added. After 10 min, (3-bromopropoxy)-tert-butyldimethylsilane (4.56 g, 4.17 mL, 18.0 mmol) in THF (20 mL) was slowly added at RT under argon. During the addition, the temperature was maintained in the range of 30−35°C. After the addition was completed, the reaction mixture was stirred at 40°C for 1 h. To the above solution, crude aldehyde 10 (4.34 g, 12.2 mmol) in THF (10 mL) was added dropwise. After the addition was completed, the reaction mixture was stirred for 1 h at RT. Then, the reaction mixture was treated with a saturated aqueous NH 4 Cl solution (50 mL) and extracted using EtOAc. The organic phase was washed with brine, dried, concentrated in vacuo, and purified using chromatography on silica gel (hexane/EtOAc, 95:5) to give alcohol 12 (4.83 g, 75%) as a colorless oil. Mixture of two diastereomers, IR (neat) To a stirred solution of alcohol 12 (1.93 g, 3.66 mmol) in anhydrous THF (40 mL), sodium hydride (60% dispersion in mineral oil, 292.8 mg, 7.32 mmol) was added under argon.
After stirring at reflux for 5 min, benzyl bromide (0.790 mL, 6.59 mmol) was added, followed by TBAI (20 mol%, 271 mg, 0.732 mmol). The reaction was stirred at 50°C for 24 h. After cooling to RT, the reaction mixture was diluted with EtOAc (50 mL) and quenched by careful addition of a saturated aqueous NaHCO 3 solution (50 mL). The phases were separated, and the aqueous layer was extracted using EtOAc (2 × 50 mL). The combined organic phases were washed with water (50 mL) and brine (50 mL), dried, and concentrated in vacuo. Purification using column chromatography on silica gel (hexane/EtOAc, 95:5) gave fully protected triol 13 Amide 14.
To a stirred solution of amine 13 (526 mg, 1.02 mmol) in CH 2 Cl 2 (3.5 mL) at 0°C, excess Et 3 N (0.720 mL, 5.15 mmol) was added, followed by dropwise addition of acetyl chloride (160 mg, 0.15 mL, 2.04 mmol). After 30 min, the reaction mixture was diluted with CH 2 Cl 2 , and a few drops of water were added. The reaction mixture was washed with a saturated aqueous NaHCO 3 solution and brine. The combined organic phases were dried and concentrated in vacuo to give amide 14 (512 mg, 90%) as a colorless oil. An analytically pure sample of this compound was obtained using chromatography over silica gel (CHCl 3 /CH 3 Carboxylic Acid 3.
To a stirred solution of ester 24 (6.3 mg, 0.018 mmol) in THF (0.075 mL) and CH 3 OH (0.038 mL), lithium hydroxide monohydrate (7.6 mg, 0.18 mmol) in water (0.038 mL) was added at RT. After 24 h, the pH was adjusted to 1.0 by the addition of HCl 2 N (0.1 mL), and the solution was extracted using ethyl acetate (3 × 5 mL). The organic phase was dried and evaporated in vacuo to give acid 3 (4.5 mg, 79%) as a colorless oil. 1 To a stirred solution of Meldrum's acid (1.60 g, 11.1 mmol) and DMAP (1.57 g, 12.9 mmol) in CH 2 Cl 2 (60 mL), Boc-(L)-Phe-OH (2.44 g, 9.21 mmol) was added followed by EDC·HCl (1.76 g, 11.1 mmol) at 0°C. The yellow mixture was stirred overnight at RT, then poured into EtOAc (200 mL), and sequentially washed with brine (2 × 100 mL), 5% citric acid solution (3 × 300 mL), and again brine (1 × 300 mL). The organic phase was refluxed for 1 h and evaporated under reduced pressure to give compound 25 (2.69 g) that was applied to the next step without further purification. Pyrrolinone 4.
To a stirred solution of pyrrolinone 25 (1.0 g, 3.46 mmol) and triphenylphospine (1.36 g, 5.19 mmol) in CH 2 Cl 2 (20 mL), CH 3 OH (0.21 mL, 5.19 mmol) and diisopropyl azodicarboxylate (DIAD) (1.0 mL, 5.19 mmol) were added at 0°C under argon. The reaction mixture was allowed to warm to RT, and after 6 h, it was concentrated in vacuo. Purification using column chromatography over silica gel (hexane/EtOAc, 6:4) gave Boc-protected pyrrolinone 38 (621 mg, 57% over three steps) as a colorless oil. To a stirred solution of pyrrolinone 4 (9.9 mg, 0.049 mmol) in THF (0.1 mL), nBuLi (0.020 mL, 0.033 mmol, 1.6 M soln in hexane) was added dropwise at −78°C. After 15 min, a solution of pentafluorophenyl ester 26 (1.5 mg, 0.0031 mmol) in THF (0.1 mL) was added via a syringe. After 2 h, the reaction was quenched with a saturated aqueous NH 4 Cl solution (1 mL) and extracted using EtOAc (3 × 10 mL). The organic phase was washed with water (6 mL) and brine (6 mL), dried, and concentrated in vacuo. The crude was subjected to reversed-phase high-performance liquid chromatography 
